Sarepta defies FDA's request to halt Elevidys shipments, while GSK faces setbacks as an FDA panel rejects its blood cancer drug Blenrep, casting doubt on its comeback and causing stock decline.
Why World Pulse Now?
Global Coverage
All major sources, one page
Emotional Lens
Feel the mood behind headlines
Trending Topics
Know what’s trending, globally
Read Less, Know More
Get summaries. Save time
Live Stats
7,345
105
204
3 hours ago
Mobile App
Available on iOS & AndroidThe mobile app adds more ways to stay informed — including offline reading, voice-enabled summaries, and personalized trend alerts.
1-Minute Daily Briefing
Stay sharp in 60 seconds. Get concise summaries of today’s biggest stories — markets, tech, sports, and more
Why World Pulse Now?
Global Coverage
All major sources, one page
Emotional Lens
Feel the mood behind headlines
Trending Topics
Know what’s trending, globally
Read Less, Know More
Get summaries. Save time
Live Stats
7,345
105
204
3 hours ago
Mobile App
Available on iOS & AndroidThe mobile app adds more ways to stay informed — including offline reading, voice-enabled summaries, and personalized trend alerts.
1-Minute Daily Briefing
Stay sharp in 60 seconds. Get concise summaries of today’s biggest stories — markets, tech, sports, and more